IMMUCELL CORPORATION - COMMON STOCK
5.0000
18-February-25 13:40:05
15 minutes delayed
Stocks
-0.0500
-0.99%
Today's range
5.0000 - 5.2519
ISIN
N/A
Source
NASDAQ
-
NetDania - New 12 months Low: IMMUCELL CORPORATION - COMMON STOCK
04 Jun 2024 09:45:38 By NetDania Notify
-
NetDania - New 12 months Low: IMMUCELL CORPORATION - COMMON STOCK
31 May 2024 12:04:29 By NetDania Notify
-
ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2024
14 May 2024 16:05:00 By Nasdaq GlobeNewswire
-
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2024
08 May 2024 13:00:48 By Nasdaq GlobeNewswire
-
ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024
09 Apr 2024 16:05:00 By Nasdaq GlobeNewswire
-
ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023
27 Feb 2024 16:05:00 By Nasdaq GlobeNewswire
-
ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2023
16 Feb 2024 09:30:00 By Nasdaq GlobeNewswire
-
ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 2023
08 Jan 2024 16:05:22 By Nasdaq GlobeNewswire
-
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2023
13 Nov 2023 16:05:00 By Nasdaq GlobeNewswire
-
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2023
07 Nov 2023 12:15:19 By Nasdaq GlobeNewswire
-
ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2023
05 Oct 2023 16:05:00 By Nasdaq GlobeNewswire
-
ImmuCell Announces Submission of CMC Technical Section to the FDA
29 Aug 2023 08:00:00 By Nasdaq GlobeNewswire
-
ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2023
10 Aug 2023 16:05:01 By Nasdaq GlobeNewswire
-
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2023
07 Aug 2023 12:00:00 By Nasdaq GlobeNewswire
-
ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2023
11 Jul 2023 16:05:18 By Nasdaq GlobeNewswire
-
ImmuCell Announces Change in Timing of Anticipated FDA Submission
28 Jun 2023 16:05:00 By Nasdaq GlobeNewswire
-
ImmuCell Appoints Bryan K. Gathagan to Board of Directors
21 Jun 2023 16:05:22 By Nasdaq GlobeNewswire
-
ImmuCell Announces Approval of Principal Terms of a $3 Million Debt Facility
15 Jun 2023 16:05:02 By Nasdaq GlobeNewswire
-
ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders
16 May 2023 09:00:00 By Nasdaq GlobeNewswire
-
ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2023
11 May 2023 16:05:01 By Nasdaq GlobeNewswire